Loading organizations...
Surplus Capital Agency offers diversified loan products exclusively for small and medium-sized enterprises. The firm provides tailored financial solutions addressing the varied capital requirements of businesses, enhancing their access to funding often difficult to obtain traditionally. This approach supports business continuity and expansion for its client base.
The company was founded in 2021, establishing operations in Albuquerque, New Mexico, United States. Information regarding its founders and the specific insights driving its inception is not publicly detailed. The firm began with an objective to serve the critical financial demands of the small and medium enterprise sector.
Surplus Capital Agency primarily serves the financial needs of small and medium-sized businesses. Its core mission is to empower these enterprises by delivering essential financing, fostering their sustained growth, innovation, and economic contribution. The company aspires to be a significant partner within the thriving SME ecosystem.
Surplus Capital has 1 tracked investment across 1 company. The latest tracked deal is $50.0M Series A in Neukio Biotherapeutics in September 2022.
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 4, 2022 | Neukio Biotherapeutics | $50.0M Series A | — | IDG Capital, Lilly Asia Ventures, Sherpa Healthcare Partners |
